Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;8(3):441-446.
doi: 10.1002/iid3.326. Epub 2020 Jul 2.

Phenotypically defined subpopulations of circulating follicular helper T cells in common variable immunodeficiency

Affiliations

Phenotypically defined subpopulations of circulating follicular helper T cells in common variable immunodeficiency

Sait Yesillik et al. Immun Inflamm Dis. 2020 Sep.

Abstract

Background: Common variable immunodeficiency (CVID) is characterized by low immunoglobulin G and IgA/IgM, decreased switched memory B cells, impaired response to vaccine, and an increased susceptibility to infections and autoimmunity. TFH cells play an important role in germinal center reaction where it supports isotype switching, somatic hypermutation, generation of memory B cells, and differentiation of B cells to plasma cells. The objective was to study the distribution of three subsets of TFH cells and their relationship with autoimmune diseases associated with CVID.

Methods: TFH cells have been divided into TFH 1 (interleukin 21 [IL-21] and interferon γ), TFH 2 (IL-21 and IL-4), and TFH 17 (IL-21 and IL-17) cells. Mononuclear cells from 25 patients with CVID and age and gender-matched controls were stained with various monoclonal antibodies (anti-CD4 APC, anti-CXCR5 FITC, anti-CCR6 PerCP, and anti-CXCR3 PE) and isotype controls and analyzed for TFH 1 (CD4+ CXCR5+ CXCR3+ CCR6- ), TFH 2 (CD4+ CXCR5+ CXCR3- CCR6- ), and TFH 17 (CD4+ CXCR5+ CXCR3- CCR6+ ) cells by multicolor flow cytometry. Twenty thousand cells were acquired and analyzed by FlowJo software. Statistical analysis of comparison of patients and healthy controls was performed by paired t test using PRISM 7 software.

Results: TFH 2 and TFH 17 cells subpopulations of TFH cells were significantly decreased (P < .003 and P < .006, respectively) in CVID as compared with controls. No significant difference was observed in any of TFH cell subpopulations between CVID with and those without autoimmunity group.

Conclusion: Alterations in TFH cell subpopulation may play a role in defects in B cell compartment in CVID.

Keywords: CVID; autoimmunity; follicular helper T cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interests.

Figures

Figure 1
Figure 1
TFH cell subsets in CVID and controls. Mononuclear cells from 25 CVID patients and healthy controls were stained with monoclonal antibodies and isotype. CVID, common variable immunodeficiency
Figure 2
Figure 2
TFH cell subsets relations to autoimmune diseases in CVID. TFH1, TFH2, and TFH17 subsets and TFH1/TFH17 ratio were compared for CVID patients with autoimmune diseases (n = 7) and without autoimmune diseases (n = 18). CVID, common variable immunodeficiency

References

    1. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan‐American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93:190‐197. - PubMed
    1. Dong J, Liang H, Wen D, Wang J. Adult common variable immunodeficiency. Am J Med Sci. 2016;351:239‐243. - PubMed
    1. Saikia B, Gupta S. Common variable immunodeficiency. Indian J Pediatr. 2016;83:338‐344. - PubMed
    1. Bonilla FA, Barlan I, Chapel H, et al. International consensus document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4:38‐59. - PMC - PubMed
    1. Gathmann B, Mahlaoui N, European Society for Immunodeficiencies Registry Working Party , et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency J Allergy Clin Immunol. 134, 2014:116‐126. 10.1016/j.jaci.2013.12.1077 - DOI - PubMed

Publication types

Substances